Serologicals Corporation (SERO) Release: Upstate Introduces New Red-Shifted KinEASE FP Assays
10/19/2005 5:09:46 PM
ATLANTA--(BUSINESS WIRE)--May 27, 2005--Serologicals Corporation (NASDAQ: SERO) today announced that Upstate Group, its wholly owned subsidiary, has introduced a new red-shifted assay to its fluorescence polarization products platform.
Upstate's KinEASE(TM) FP product previously was limited to use with the green-shifted dye fluorescein. The new red-shifted KinEASE(TM) FP assay is farther red on the wavelength spectrum thereby producing even clearer results. The new emissions spectra reduces compound interference issues that tend to occur in the bluer end of the spectrum. It is ideal for in-house use on smaller sample sizes from bench-top plate screening through robotic primary screening. The KinEASE(TM) FP two-plate kits are available for determining the activity of 80 different protein kinases.
comments powered by